SEC Form 4 · accession 0001649989-26-000005
Outlook Therapeutics, Inc. · OTLK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yezan Munther Haddadin
Director
Period of report
Jun 2, 2026
Accepted (ET)
Jun 3, 2026 · 6:03 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001649989
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 2, 2026 | P | 29,000 | $0.8326 | A | 66,167 | D |
Table II — derivative securities
No Table II lines on this filing.